Abstract
Introduction: Ultra-Performance Liquid Chromatographic (UPLC) method enables analyst to establish an analysis at higher pressure than High Performance Liquid Chromatographic (HPLC) method towards liquid chromatographic methods. UPLC method provides the opportunity to study a higher pressure compared to HPLC, and therefore smaller column in terms of particle size and internal diameter are generally used in drug analysis. The UPLC method has attracted gradually due to its advantages such as short analysis time, the small amount of waste reagents and the significant savings in the cost of their destruction process. In this review, the recent selected studies related to the UPLC method and its method validation are summarized. The drug analyses and the results of the studies which were investigated by UPLC method, with certain parameters from literature are presented.
Background: Quantitative determination of drug active substances by High-Performance Liquid Chromatography (HPLC) from Liquid Chromatography (LC) methods has been carried out since the 1970's with the use of standard analytical LC methods. In today's conditions, rapid and very fast even ultra-fast, flow rates are achieved compared to conventional HPLC due to shortening analysis times, increasing method efficiency and resolution, reducing sample volume (and hence injection volume), reducing waste mobile phase. Using smaller particles, the speed and peak capacity are expanding to new limit and this technology is named as Ultra Performance Liquid Chromatography. In recent years, as a general trend in liquid chromatography, ultra-performance liquid chromatography has taken the place of HPLC methods. The time of analysis was for several minutes, now with a total analysis time of around 1-2 minutes. The benefits of transferring HPLC to UPLC are much better understood when considering the thousands of analyzes performed for each active substance, in order to reduce the cost of analytical laboratories where relevant analysis of drug active substances are performed without lowering the cost of research and development activities.
Methods: The German Chemist Friedrich Ferdinand Runge, proposed the use of reactive impregnated filter paper for the identification of dyestuffs in 1855 and at that time the first chromatographic method in which a liquid mobile phase was used, was reviewed. Christian Friedrich Chönbein, who reported that the substances were dragged at different speeds in the filter paper due to capillary effect, was followed by the Russian botanist Mikhail S. Tswet, who planted studies on color pigment in 1906. Tswet observes the color separations of many plant pigments, such as chlorophyll and xanthophyll when he passes the plant pigment extract isolated from plant through the powder CaCO3 that he filled in the glass column. This method based on color separation gives the name of "chromatographie" chromatography by using the words "chroma" meaning "Latin" and "graphein" meaning writing.
Results and Conclusion: Because the UPLC method can be run smoothly at higher pressures than the HPLC method, it offers the possibility of analyzing using much smaller column sizes and column diameters. Moreover, UPLC method has advantages, such as short analysis time, the small amount of waste reagents and the significant savings in the cost of their destruction process. The use of the UPLC method especially analyses in biological samples such as human plasma, brain sample, rat plasma, etc. increasingly time-consuming due to the fact that the analysis time is very short compared to the HPLC, because of the small amount of waste analytes and the considerable savings in their cost.
Keywords: Analysis, biological sample, HPLC, pharmaceuticals, UPLC, validation, LC.
Graphical Abstract
[1]
Colin, H.; Guiochon, G. Introduction to reversed-phase high-performance liquid chromatography. J. Chromatogr. A, 1977, 141, 289-312.
[2]
Swartz, M.E. UPLCTM: An introduction and review. J. Liq. Chromatogr. Relat. Technol., 2005, 28(7-8), 1253-1263.
[3]
Chesnut, S.M.; Salisbury, J.J. The role of UHPLC in pharmaceutical development. J. Sep. Sci., 2007, 30(8), 1183-1190.
[4]
Avula, B.; Wang, Y.H.; Rumalla, C.S.; Ali, Z.; Smillie, T.J.; Khan, I.A. Analytical methods for determination of magnoflorine and saponins from roots of caulophyllum thalictroides (L.) Michx. Using UPLC, HPLC and HPTLC. J. Pharm. Biomed. Anal., 2011, 56(5), 895-903.
[5]
Wren, S.A.C.; Tchelitcheff, P. Use of ultra-performance liquid chromatography in pharmaceutical development. J. Chromatogr. A, 2006, 1119(1-2), 140-146.
[6]
Zaza, S.; Lucini, S.M.; Sciascia, F.; Ferrone, V.; Cifelli, R.; Carlucci, G.; Locatelli, M. Recent advances in the separation and determination of impurities in pharmaceutical products. Instrum. Sci. Technol., 2015, 43(2), 182-196.
[7]
Primavera, R.; Di Francesco, M.; De Cola, A.; De Laurenzi, V.; Paolino, D.; Ciancaioni, M.; Carafa, M.; Celia, C.; Di Ilio, C.; Di Stefano, A. HPLC-FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples. Colloids Surf. B Biointerfaces, 2015, 135, 575-580.
[8]
Locatelli, M.; Sciascia, F.; Cifelli, R.; Malatesta, L.; Bruni, P.; Croce, F. Analytical methods for the endocrine disruptor compounds determination in environmental water samples. J. Chromatogr. A, 2016, 1434, 1-18.
[9]
Locatelli, M.; Melucci, D.; Carlucci, G.; Locatelli, C. Recent HPLC strategies to improve sensitivity and selectivity for the analysis of complex matrices. Instrum. Sci. Technol., 2012, 40(2-3), 112-137.
[10]
Paul, M.S.; Mytelka, D.S.; Dunwiddie, T.C.; Persinger, C.C.; Munos, B.H.; Lindborg, S.R.; Schacht, A.L. How to improve R&D productivity: The pharmaceutical industry’s grand challenge. Nat. Rev. Drug Discov., 2010, 9, 203-214.
[11]
Gumustas, M.; Kurbanoglu, S.; Uslu, B.; Ozkan, S.A. UPLC versus HPLC on drug analysis: Advantageous, applications and their validation parameters. Chromatographia, 2013, 76, 1365-1427.
[12]
Guillarme, D.; Nguyen, D.T.T.; Rudaz, S.; Veuthey, J.L. Recent developments in liquid chromatography-impact on qualitative and quantitative performance. J. Chromatogr. A, 2007, 1149(1), 20-29.
[13]
Guillarme, D.; Nguyen, D.T.T.; Rudaz, S.; Veuthey, J.L. Method transfer for fast liquid chromatography in pharmaceutical analysis: Application to short columns packed with small particle. Part I: Isocratic Separation. Eur. J. Pharm. Biopharm., 2007, 66, 475-482.
[14]
Guillarme, D.; Nguyen, D.T.T.; Rudaz, S.; Veuthey, J.L. Method transfer for fast liquid chromatography in pharmaceutical analysis: Application to short columns packed with small particle. part ii: gradient experiments. Eur. J. Pharm. Biopharm., 2008, 68(2), 430-440.
[15]
Olšovská, J.; Jelínková, M.; Man, P.; Koběrská, M.; Janata, J.; Flieger, M. High-Throughput Quantification of Lincomycin Traces in Fermentation Broth of Genetically Modified Streptomyces Spp. Comparison of Ultra-Performance Liquid Chromatography and High-Performance Liquid Chromatography with UV Detection. J. Chromatogr. A, 2007, 1139(2), 214-220.
[16]
Klimczak, I.; Gliszczynska-Swiglo, A. Comparison of UPLC and HPLC Methods for Determination of Vitamin C. Food Chem., 2015, 175, 100-105.
[17]
Nováková, L.; Solichová, D.; Solich, P. Advantages of ultra performance liquid chromatography over High-Performance Liquid Chromatography: Comparison of different analytical approaches during analysis of diclofenac gel. J. Sep. Sci., 2006, 29(16), 2433-2443.
[18]
Nováková, L.; Matysová, L.; Solich, P. Advantages of application of uplc in pharmaceutical analysis. Talanta, 2006, 68(3), 908-918.
[19]
Natishan, T.K. Developments in fast liquid chromatographic analysis of pharmaceuticals. J. Liq. Chromatogr. Relat. Technol., 2011, 34(13), 1133-1156.
[20]
Anft, B. Friedlieb Ferinand Runge: A forgotten chemist of the nineteenth century. J. Chem. Educ., 1955, 32, 566.
[24]
Knox, J.H. Scott, H.P. B and C Terms in the Van Deemter Equation for Liquid Chromatography. J. Chromatogr. A, 1983, 282, 297-313.
[25]
Jin, Y.; Xue, X.; Shi, H.; Xiao, Y.; Zhang, F.; Liang, X. HPLC and UPLC Switch for TCM Analysis. World Sci. Technol., 2008, 10(1), 80-84.
[26]
Chen, S.; Kord, A. Theoretical and experimental comparison of mobile phase consumption between ultra-high-performance liquid chromatography and high performance liquid chromatography. J. Chromatogr. A, 2009, 1216(34), 6204-6209.
[27]
Churchwell, M.I.; Twaddle, N.C.; Meeker, L.R.; Doerge, D.R. Improving LC-MS sensitivity through increases in chromatographic performance: Comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2005, 825(2), 134-143.
[28]
Jastrebova, J.; Strandler, H.S.; Patring, J.; Wiklund, T. Comparison of UPLC and HPLC for analysis of dietary folates. Chromatographia, 2011, 73(3-4), 219-225.
[29]
Mellors, J.S.; Jorgenson, J.W. Use of 1.5-Mm Porous Ethyl-Bridged hybrid particles as a stationary-phase support for reversed-phase ultrahigh-pressure liquid chromatography. Anal. Chem., 2004, 76(18), 5441-5450.
[30]
Nováková, L.; Kaufmannová, I.; Jánská, R. Evaluation of hybrid hydrophilic interaction chromatography stationary phases for ultra-hplc in analysis of polar pteridines. J. Sep. Sci., 2010, 33(6-7), 765-772.
[31]
Taverniers, I.; De Loose, M.; Van Bockstaele, E. Trends in quality in the analytical laboratory. ii. analytical method validation and quality assurance. TrAC -. Trends Anal. Chem., 2004, 23(8), 535-552.
[32]
Riley, CM, Rosanske, T. Development and Validation of Analytical Methods; Amsterdam, The Netherlands: Elsevier, 1996.
[33]
Ermer, J.; Miller, J. Method Validation in Pharmaceutical Analysis, 1st ed; Germany: Wiley-VCH Pub, 2005.
[34]
CH Guidelines Topic Validation of Analytical Procedures, Methodology International Conference on Harmonization, Brussels, Belgium.;. 1995.
[35]
The United States Pharmacopeia, (The USP 40), The Official Compendia of Standards, United States Pharmacopeial Convention; MD, Rockville, USA., 2017.
[36]
Fan, L. hua; Li, X.; Chen, D. yuan; Zhang, N.; Wang, Y.; Shan, Y.; Hu, Y.; Xu, R.Ai; Jin, J.; Ge, R. S. Determination of Acacetin in Rat Plasma by UPLC-MS/MS and its application to a pharmacokinetic study. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 986, 18-22.
[37]
Qiu, X.; Lou, D.; Su, D.; Liu, Z.; Gao, P.; Zhang, N.S. Simultaneous determination of acetaminophen and dihydrocodeine in human plasma by UPLC-MS/MS: Its pharmacokinetic application. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 992, 91-95.
[38]
Al-Amri, K. A.; Mohsin, K.; Alanazi, F. K. Development and validation of a UPLC method for quantification of antiviral agent, acyclovir in lipid-based formulations., 2014.
[http://dx.doi.org/10.1016/ j.arabjc.2014.08.024]
[http://dx.doi.org/10.1016/ j.arabjc.2014.08.024]
[39]
Zhang, L.; Wang, Z.H.; Li, H.; Liu, Y.; Zhao, M.; Jiang, Y.; Zhao, W.S. Simultaneous determination of 12 Illicit drugs in whole blood and urine by solid phase extraction and UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2014, 955, 10-19.
[40]
Uddin, M.N.; Das, S.; Khan, S.H.; Shill, S.K.; Bhuiyan, H.R.; Karim, R. Simultaneous determination of amoxicillin and chloramphenicol and their drug interaction study by the validated UPLC Method. J. Taibah Univ. Sci., 2016, 10(5), 755-765.
[41]
Liu, Y.; Zhu, K.; Wang, J.; Huang, X.; Wang, G.; Li, C.; Cao, J.; Ding, S. Simultaneous detection and comparative pharmacokinetics of Amoxicillin, Clavulanic Acid and Prednisolone in Cows’ Milk by UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2016, 1008, 74-80.
[42]
Bonneau, N.; Schmitz-Afonso, I.; Brunelle, A.; Touboul, D.; Champy, P. Method development for quantification of the environmental neurotoxin annonacin in rat plasma by UPLC-MS/MS and application to a pharmacokinetic study. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 1004, 46-52.
[43]
Abdelbary, G.; Nebsen, M. Application of a Novel UPLC-MS/MS method for the pharmacokinetic/bioequivalence determination of atorvastatin and ezetimibe in human plasma. J. Pharm. Res., 2013, 7, 24-32.
[44]
Yan, H.; Sun, Y.; Zhang, Q.; Yang, M.; Wang, X.; Wang, Y.; Yu, Z.; Zhao, Y. Simultaneous determination and pharmacokinetic study of atractylenolide I, II and III in rat plasma after intragastric administration of baizhufuling extract and atractylodis extract by UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 993, 86-92.
[45]
Gong, C.; Wang, J.; Sun, Y.; Ding, D.; Zhong, L.; Zhu, M.; Sun, J.; Zhang, X. UPLC-MS/MS for the determination of azilsartan in beagle dog plasma and its application in a pharmacokinetics study. Asian J. Pharm. Sci., 2015, 10, 247-253.
[46]
Atici, E.B.; Karliga, B. Identification, synthesis and characterization of process related impurities of benidipine hydrochloride, stress-testing/stability studies and HPLC/UPLC method validations. J. Pharm. Anal., 2015, 5, 256-268.
[47]
Yuan, Z.W.; Leung, E.L.H.; Fan, X.X.; Zhou, H.; Ma, W.Z.; Liu, L.; Xie, Y. Quantitative evaluation of berberine subcellular distribution and cellular accumulation in non-small cell lung cancer cells by UPLC-MS/MS. Talanta, 2015, 144, 20-28.
[48]
Wang, X.; Wang, S.; Ma, J.; Ye, T.; Lu, M.; Fan, M.; Deng, M.; Hu, L.; Gao, Z. Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS/MS. J. Pharm. Biomed. Anal., 2015, 115, 368-374.
[49]
Xu, Y.; Huang, X. Ce; Dai, S.; Xiao, Y.; Zhou, M. tao. A simple method for the determination of bosutinib in rat plasma by UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 1004, 93-97.
[50]
Zhang, Q.; Yuan, Y.; Cui, J.; Xiao, T.; Deng, Z.; Jiang, D. Determination of a potential antitumor quassinoid in rat plasma by UPLC-MS/MS and its application in a pharmacokinetic study. J. Pharm. Biomed. Anal., 2016, 124, 143-148.
[51]
Liu, M.; Liu, X.; Wang, H.; Xiao, H.; Jing, F.; Tang, L.; Li, D.; Zhang, Y.; Wu, H.; Yang, H. Metabolomics study on the effects of buchang naoxintong capsules for treating cerebral ischemia in rats using UPLC-Q/TOF-MS. J. Ethnopharmacol., 2016, 180, 1-11.
[52]
Wang, X.; Wang, S.; Lin, F.; Zhang, Q.; Chen, H.L.; Wang, X.; Wen, C.; Ma, J.; Hu, L. Pharmacokinetics and tissue distribution model of cabozantinib in rat determined by UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 983, 125-131.
[53]
Singh, B.; Lokhandae, R.S.; Dwivedi, A.; Sharma, S.; Dubey, N. Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLC-MS/MS and its application in bioequivalence studies. J. Pharm. Anal., 2014, 4, 144-152.
[54]
Ameeduzzafar.; Ali, J.; Ali, A. Development and validation of UPLC/ESI-Q-TOF-MS for carteolol in aqueous humour: Stability, stress degradation and application in pharmacokinetics of nanoformulation. Arab. J. Chem., 2017, 10, S2969-S2978.
[55]
Ma, Y.; Gao, S.; Hu, M. Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2015, 1001, 202-211.
[56]
Bhatt, N.M.; Chavada, V.D.; Patel, D.P.; Sharma, P.; Sanyal, M.; Shrivastav, P.S. Determination of cilostazol and its active metabolite 3,4-Dehydro cilostazol from small plasma volume by UPLC-MS/MS. J. Pharm. Anal., 2015, 5, 1-11.
[57]
Hafez, H.M.; Elshanawany, A.A.; Abdelaziz, L.M.; Mohram, M.S. Design of experiment utilization to develop a simple and robust RP- UPLC technique for stability indicating method of ciprofloxacin hydrochloride and metronidazole in tablets. Eurasian J. Anal. Chem, 2015, 10(2), 84-105.
[58]
Yang, G.; Gao, S.; Sun, R.; Yin, T.; Hu, M. Development and validation of an UPLC-MS/MS method for the quantification of columbin in biological matrices: Applications to absorption, metabolism, and pharmacokinetic studies. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 1002, 13-18.
[59]
Wang, L.; Lu, N.; Zhao, L.; Qi, C.; Zhang, W.; Dong, J.; Hou, X. Characterization of stress degradation products of curcumin and its two derivatives by UPLC–DAD–MS/MS. Arab. J. Chem., 2016.
[http://dx.doi.org/10.1016/j.arabjc.2016.02.003]
[http://dx.doi.org/10.1016/j.arabjc.2016.02.003]
[60]
Kuhn, J.; Gripp, T.; Flieder, T.; Dittrich, M.; Hendig, D.; Busse, J.; Knabbe, C.; Birschmann, I. UPLC-MRM mass spectrometry method for measurement of the coagulation inhibitors dabigatran and rivaroxaban in human plasma and its comparison with functional assays. PLoS One, 2015, 10(12), 1-19.
[61]
Zhang, W.M.; Qiang, W.; Ying-Fei, W.; Ming, S.; Wang, R. Development and validation of a sensitive uplc-ms/ms method for the simultaneous determination of dapoxetine and its two metabolites in human plasma. J. Pharm. Biomed. Anal., 2016, 119, 45-49.
[62]
Gudlawar, S.K.; Pilli, N.R.; Siddiraju, S.; Dwivedi, J. Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC-MS/MS. J. Pharm. Anal., 2017, 7, 196-202.
[63]
Elzayat, E.M.; Ibrahim, M.F.; Abdel-Rahman, A.A.; Ahmed, S.M.; Alanazi, F.K.; Habib, W.A. A Validated stability-indicating UPLC method for determination of diclofenac sodium in its pure form and matrix formulations. Arab. J. Chem., 2017, 10, S3245-S3254.
[64]
Liu, H.; Xu, H.; Song, W.; Zhang, Y.; Yu, S.; Huang, X. Validated UPLC/MS/MS assay for quantitative bioanalysis of elbasvir in rat plasma and application to pharmacokinetic study. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2016, 1015, 150-156.
[65]
De Nicolò, A.; Simiele, M.; Pensi, D.; Boglione, L.; Allegra, S.; Di Perri, G.; D’Avolio, A. UPLC-MS/MS method for the simultaneous quantification of Anti-HBV Nucleos(t)ides Analogs: Entecavir, Lamivudine, Telbivudine and Tenofovir in Plasma of HBV Infected patients. J. Pharm. Biomed. Anal., 2015, 114, 127-132.
[66]
Rane, S.S.; Ajameri, A.; Mody, R.; Padmaja, P. Development and validation of RP-HPLC and RP-UPLC methods for quantification of erythropoietin formulated with human serum albumin. J. Pharm. Anal., 2012, 2(2), 160-165.
[67]
Chunduri, R.H.B.; Dannana, G.S. Development and validation of a high throughput UPLC-MS/MS method for simultaneous quantification of esomeprazole, rabeprazole and levosulpiride in Human Plasma. J. Pharm. Anal., 2016, 6(3), 190-198.
[68]
Gao, S.; Zhao, J.; Yin, T.; Ma, Y.; Xu, B.; Moore, A.N.; Dash, P.K.; Hu, M. Development and Validation of an UPLC-MS/MS method for the quantification of ethoxzolamide in blood, brain tissue, and bioequivalent buffers: Applications to Absorption, Brain Distribution, and Pharmacokinetic Studies. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 986, 54-59.
[69]
Kako, K.; Nakamura, A.; Nagashima, Y.; Ishida, J.; Fukamizu, A. Detection of ethanolamine altering in fetuses of pregnancy-associated hypertensive mice treated with vasodepressors by using UPLC and MALDI-TOF/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 1006, 93-98.
[70]
Reddy, T.V.B.; Reddy, N.S.; Reddy, S.R.P.; Ramu, G.; Rambabu, C. Optimized and validated stability indicating rp-uplc method for the determination of famotidine in pharmaceutical formulations. J. Pharm. Res., 2013, 6, 865-869.
[71]
Wang, X.; Zheng, Z.; He, G.; Mai, L.; Zhou, Z.; Zhong, S.; Lin, Q.; Shan, Z.; Deng, C.; Yang, M. Rapid determination of Fenoldopam in human plasma by UPLC-MS/MS for pharmacokinetic analysis in patients. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 978, 78-82.
[72]
Feng, W.H.; Zhang, H.H.; Zhang, Y.; Sun, M.; Niu, J.L. Determination of galangin in rat plasma by UPLC and pharmacokinetic study. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 998, 26-30.
[73]
Ding, R.; Jian, Y.; Kan, H.; Liu, Z.Y.; Liu, S.; Liu, Z.Q.; Zhou, J. Studies on the intestinal absorption of the alkaloids in the gancaofuzi decoction in a Caco-2 Cell culture system by UPLC-MS/MS analysis. Chin. Chem. Lett., 2016, 27(6), 915-919.
[74]
Qiu, X.; Wang, H. Wei; Yuan, Y.; Wang, Y.F.; Sun, M.; Huang, X. sun. An UPLC-MS/MS method for the analysis of glimepiride and fluoxetine in human plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 980, 16-19.
[75]
Liu, C.; Hua, Z.; Bai, Y. Classification of illicit heroin by UPLC-Q-TOF analysis of acidic and neutral manufacturing impurities. Forensic Sci. Int., 2015, 257, 196-202.
[76]
Ma, J.; Wang, S.; Huang, X.; Geng, P.; Wen, C.; Zhou, Y.; Yu, L.; Wang, X. Validated UPLC-MS/MS method for determination of hordenine in rat plasma and its application to pharmacokinetic study. J. Pharm. Biomed. Anal., 2015, 111, 131-137.
[77]
Dinç, E.; Ertekin, Z.C. Three-Way analysis of the UPLC-PDA dataset for the multicomponent quantitation of hydrochlorothiazide and olmesartan medoxomil in tablets by parallel factor analysis and three-way partial least squares. Talanta, 2016, 148, 144-152.
[78]
Lu, Y.; Li, N.; Deng, Y.; Zhao, L.; Guo, X.; Li, F.; Xiong, Z. Simultaneous determination of icariin, naringin and osthole in rat plasma by UPLC-MS/MS and its application for pharmacokinetic study after oral administration of gushudan capsules. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 993, 75-80.
[79]
Li, Y.; Zeng, R.J.; Chen, J.Z.; Wu, Y. Bin; Chou, G. X.; Gao, Y.; Shao, J. W.; Cai, H. Z.; Jia, L. Pharmacokinetics and Metabolism Study of Isoboldine, a Major Bioactive Component from Radix Linderae in Male Rats by UPLC-MS/MS. J. Ethnopharmacol., 2015, 171, 154-160.
[80]
Song, G.; Jin, M.; Du, Y.; Cao, L.; Xu, H. UPLC-QTOF-MS/MS based screening and identification of the metabolites in rat bile after oral administration of imperatorin. J. Chromatogr. B ., 2016, 1022, 21-29.
[81]
Basu, S.; Zeng, M.; Yin, T.; Gao, S.; Hu, M. Development and Validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2016, 1015, 34-41.
[82]
Zhang, W. Min; Li, R.F.; Qiu, J.F.; Zhang, Z.Y.; Wang, H.B; Bian, L.; Lei, J.H. Determination of kurarinone in rat plasma by UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 986, 31-34.
[83]
Zhang, H.; Wang, Z.; Liu, O. Simultaneous determination of Kolliphor HS15 and Miglyol 812 in microemulsion formulation by Ultra-High Performance Liquid Chromatography coupled with nano quantity analyte detector. J. Pharm. Anal., 2016, 6, 11-17.
[84]
Zhou, Y.; Liu, X.; Chen, F.; Zhang, F. Simultaneous quantitative determination of eight index constituents and compatibility changes in longchai decoction by UPLC-Q-TOF-MS. Acta Pharm. Sin. B, 2013, 3(4), 281-287.
[85]
Pan, C.; Chen, Y.; Chen, W.; Zhou, G.; Jin, L.; Zheng, Y.; Lin, W.; Pan, Z. Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2016, 1008, 255-259.
[86]
Chaudhary, D.V.; Patel, D.P.; Shah, P.A.; Shah, J.V.; Sanyal, M.; Shrivastav, P.S. Determination of lercanidipine in human plasma by an improved UPLC-MS/MS method for a bioequivalence study. J. Pharm. Anal., 2016, 6, 87-94.
[87]
Bajrai, A.A.; Ezzeldin, E.; Al-Rashood, K.A.; Raish, M.; Iqbal, M. A Validated UPLC-MS-MS assay for the rapid determination of lorcaserin in plasma and brain tissue samples. J. Anal. Toxicol., 2016, 40, 133-139.
[88]
Guo, M.; Zhao, L.; Li, M.; Fu, Q.; Pu, X.; Liu, B.; He, Z.; Yang, L. Simultaneous determination of lovastatin and its metabolite lovastatin acid in rat plasma using UPLC-MS/MS with positive/negative ion-switching electrospray ionization: Application to a pharmacokinetic study of lovastatin nanosuspension. J. Chromatogr. B., 2016, 1023-1024, 55-61.
[89]
Zhao, M.; Tao, J.; Qian, D.; Liu, P.; Shang, E.X.; Jiang, S.; Guo, J.; Su, S.L.; Duan, J.A.; Du, L. Simultaneous determination of loganin, morroniside, catalpol and acteoside in normal and chronic kidney disease rat plasma by UPLC-MS for investigating the pharmacokinetics of rehmannia glutinosa and cornus officinalis sieb drug pair extract. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2016, 1009, 122-129.
[90]
Qiu, X.; Zhao, J. long; Hao, C.; Yuan, C.; Tian, N.; Xu, Z. Sheng; Zou, R.M. Simultaneous Determination of mangiferin and neomangiferin in rat plasma by UPLC-MS/MS and its application for pharmacokinetic study. J. Pharm. Biomed. Anal., 2016, 124, 138-142.
[91]
Sowjanya, P.; Shanmugasundaram, P.; Naidu, P.; Singamsetty, S.K. Novel validated stability-indicating uplc method for the determination of metoclopramide and its degradation impurities in API and pharmaceutical dosage form. J. Pharm. Res., 2013, 6, 765-773.
[92]
Reitzle, L.; Maier, B.; Stojanov, S.; Teupser, D.; Muntau, A.C.; Vogeser, M.; Gersting, S.W. Quantification of Mevalonate-5-Phosphate using UPLC-MS/MS for determination of mevalonate kinase activity. Clin. Biochem., 2015, 48, 781-787.
[93]
Yan, H.; Song, Y.; Zhou, W.; Zhang, S. A selective and sensitive method based on UPLC-MS/MS for quantification of momordin ic in rat plasma: Application to a pharmacokinetic study. J. Pharm. Biomed. Anal. J. Pharm. Biomed., 2015, 115, 196-200.
[94]
Lin, D.; Qiao, L.; Zhang, Y.; Liu, Y.; Liu, X. Simultaneous determination of nintedanib and its metabolite by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study. J. Pharm. Biomed. Anal., 2016, 117, 173-177.
[95]
Iqbal, M.; Ezzeldin, E.; Bhat, M.A.; Raish, M.; Al-Rashood, K.A. Preclinical pharmacokinetics, tissue distribution and excretion studies of a novel anti-candidal agent-thiosemicarbazide derivative of isoniazid (TSC-INH) by validated UPLC-MS/MS assay. J. Pharm. Biomed. Anal., 2016, 117, 109-117.
[96]
Andreassen, T.N.; Falch, B.M.H.; Spigset, O. A UPLC-MSMS method for the analysis of olanzapine in serum-with particular emphasis on drug stability testing. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 1006, 112-120.
[97]
Huang, Y.; Chen, H.; He, F.; Zhang, Z.R.; Zheng, L.; Liu, Y.; Lan, Y.Y.; Liao, S.G.; Li, Y.J.; Wang, Y.L. Simultaneous determination of human plasma protein binding of bioactive flavonoids in polygonum orientale by equilibrium dialysis combined with UPLC-MS/MS. J. Pharm. Anal., 2013, 3, 376-381.
[98]
Lian, H.; Sun, J.; Zhang, T. A Rapid and sensitive determination of paclitaxel in rat plasma by UPLC-MS/MS method: Application to a pharmacokinetic study. Asian J. Pharm. Sci., 2013, 8, 199-205.
[99]
Liu, M.; Yu, Q.; Li, P.; Zhu, M.; Fang, M.; Sun, B.; Sun, M.; Sun, Y.; Zhang, P.; He, Z. Simultaneous determination of parecoxib sodium and its active metabolite valdecoxib in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study after intravenous and intramuscular administration. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2016, 1022, 220-229.
[100]
Zhao, A.Q.; Zhao, J.H.; Zhang, S.Q.; Pan, Y.Y.; Huo, X.L. Determination of Parthenolide in Rat Plasma by UPLC-MS/MS and Its Application to a Pharmacokinetic Study. J. Pharm. Biomed. Anal., 2016, 119, 99-103.
[101]
Schenk, A.; Siewert, B.; Toff, S.; Drewe, J. UPLC TOF MS for sensitive quantification of naturally occurring pyrrolizidine alkaloids in petasites hybridus extract (Ze 339). J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 997, 23-29.
[102]
Li, Y.; Zhou, G.; Peng, Y.; Tu, P.; Li, X. Screening and identification of three typical phenylethanoid glycosides metabolites from cistanches herba by human intestinal bacteria using UPLC/Q-TOF-MS. J. Pharm. Biomed. Anal., 2016, 118, 167-176.
[103]
He, X.; Zhang, Y.; Gao, H.; Li, K.; Zhang, Y.; Sun, L.; Tao, G. Simultaneous quantification of picfeltarraenins IA and IB in Rat Plasma by UPLC-MS/MS: Application to a pharmacokinetic study. J. Pharm. Biomed. Anal., 2016, 120(2), 32-37.
[104]
Sahu, K.; Shaharyar, M.; Siddiqui, A.A. Establishment of inherent stability of febuxostat and development of a validated stability-indicating method by UPLC according to ICH Requirement. Med. Chem. Res., 2017, 10, 576-582.
[105]
Sun, W.; Jiang, Z.L.; Zhou, L.; Chen, R.M.; Wang, Z.; Li, W.S.; Jiang, S.M.; Hu, G.X.; Chen, R.J. Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 981, 14-18.
[106]
Deng, L.; Li, Y.; Zhang, X.; Chen, B.; Deng, Y.; Li, Y. UPLC-MS method for quantification of pterostilbene and its application to comparative study of bioavailability and tissue distribution in normal and lewis lung carcinoma bearing mice. J. Pharm. Biomed. Anal., 2015, 114, 200-207.
[107]
Xu, R.; Gao, H.T.; Zhu, F.; Cao, W.X.; Yan, Y.H.M.; Zhou, X.; Xu, Q.; Ji, W.L. SPE-UPLC-MS/MS for the Determination of phthalate monoesters in rats urine and its application to study the effects of food emulsifier on the bioavailability of priority controlling PAEs. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2016, 1012-1013, 97-105.
[108]
Zhou, Y.; Wang, S.; Ding, T.; Chen, M.; Wang, L.; Wu, M.; Hu, G.; Lu, X. Evaluation of the effect of Apatinib (YN968D1) on Cytochrome P450 enzymes with cocktail probe drugs in rats by UPLC-MS/MS. J. Chromatogr. B Anal/ Technol. Biomed. Life Sci., 2014, 973, 68-75.
[109]
Liao, M.; Dai, C.; Liu, M.; Chen, J.; Chen, Z.; Xie, Z.; Yao, M. Simultaneous Determination of Four Furostanol Glycosides in Rat Plasma by UPLC-MS/MS and Its Application to PK Study after Oral Administration of Dioscorea Nipponica Extracts. J. Pharm. Biomed. Anal., 2016.
[110]
Iqbal, M.; Ezzeldin, E.; Al-Rashood, K.A.; Shakeel, F. A Validated UPLC-MS/MS Assay Using Negative Ionization Mode for High-Throughput Determination of Pomalidomide in Rat Plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 983, 76-82.
[111]
Liao, M.; Chen, X.; Chen, J.; Liu, M.; Wang, J.; Chen, Z.; Xie, Z.; Yao, M. Determination of Pseudoprotodioscin in Rat Plasma by UPLC-MS/MS: Assay Development and Application to Pharmacokinetic Study. J. Chromatogr. B., 2016.
[112]
Liu, J.; Fang, Y.; Yang, L.; Qin, X.; Du, G.; Gao, X.A. Qualitative, and Quantitative Determination and Pharmacokinetic Study of Four Polyacetylenes from Radix Bupleuri by UPLC-PDA-MS. J. Pharm. Biomed. Anal., 2015, 111, 257-265.
[113]
Shi, X.; Zhu, D.; Lou, J.; Zhu, B.; Hu, A. rong; Gan, D. Evaluation of a Rapid Method for the Simultaneous Quantification of Ribavirin, Sofosbuvir and Its Metabolite in Rat Plasma by UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 1002, 353-357.
[114]
Wingert, N.R.; dos Santos, N.O.; Nunes, M.A.G.; Gomes, P.; Müller, E.I.; Flores, É.M.M.; Steppe, M. Characterization of Three Main Degradation Products from Novel Oral Anticoagulant Rivaroxaban under Stress Conditions by UPLC-Q-TOF-MS/MS. J. Pharm. Biomed. Anal., 2016, 123, 10-15.
[115]
Decheng, S.; Wei, Z.; Yu, Z.; Genlong, Z.; Ruigou, W. PeiLong, W.; Xiaoou, S. Validation of a Confirmatory Method of Salbutamol in Sheep Hair by UPLC-MS/MS and Its Application to Pharmacokinetic Study. J. Pharm. Biomed. Anal., 2015, 114, 12-15.
[116]
Rezk, M.R.; Basalious, E.B.; Karim, I.A. Development of a Sensitive UPLC-ESI-MS/MS Method for Quantification of Sofosbuvir and Its Metabolite, GS-331007, in Human Plasma: Application to a Bioequivalence Study. J. Pharm. Biomed. Anal., 2015, 114, 97-104.
[117]
Chen, Y.; Zhang, S.; Chen, D.; Zhou, M.; Zheng, J.; Xiang, Z. An UPLC-MS/MS Method for Determination of Solasonine in Rat Plasma and Its Application of a Pharmacokinetic and Bioavailability Study. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2015, 985, 1-5.
[118]
Dong, Y-Y.; Mao, B.; Guan, H.; Bai, Y.; Chi, B.; Shan, Y-Y.; Lian, Q-Q.; Ge, R-S. Determination of Songorine in Rat Plasma by UPLC-MS/MS: Assay Development and Application to Pharmacokinetic Study. J. Chromatogr. B., 2015, 1002, 234-238.
[119]
Pensi, D.; De Nicolò, A.; Pinon, M.; Calvo, P.L.; Nonnato, A.; Brunati, A.; Di Perri, G.; D’Avolio, A. An UPLC-MS/MS Method Coupled with Automated on-Line SPE for Quantification of Tacrolimus in Peripheral Blood Mononuclear Cells. J. Pharm. Biomed. Anal., 2015, 107, 512-517.
[120]
Drooger, J.C.; Jager, A.; Lam, M-H.; Den Boer, M.D.; Sleijfer, S.; Mathijssen, R.H.J.; De Bruijn, P. Development and Validation of an UPLC-MS/MS Method for the Quantification of Tamoxifen and Its Main Metabolites in Human Scalp Hair. J. Pharm. Biomed. Anal., 2015, 114, 416-425.
[121]
Yang, M.; Yang, X.; An, J.; Xiao, W.; Wang, Z.; Huang, W.; Yang, Z.; Li, F. Comparative Pharmacokinetic Profiles of Tectorigenin in Rat Plasma by UPLC-MS/MS after Oral Administration of Iris Tectorum Maxim Extract and Pure Tectoridin. J. Pharm. Biomed. Anal., 2015, 114, 34-41.
[122]
Ram, V.; Kher, G.; Dubal, K.; Dodiya, B.; Joshi, H. Development and Validation of a Stability Indicating UPLC Method for Determination of Ticlopidine Hydrochloride in Its Tablet Formulation. Saudi Pharm. J., 2011, 19(3), 159-164.
[123]
Ni, K-H.; Wen, Z-D.; Huang, X-C.; Wang, C-X.; Ye, T-T.; Hu, G-X.; Zhou, M-T. Determination of Trifolirhizin in Rat Plasma by UPLC: Application to a Pharmacokinetic Study. J. Chromatogr. B., 2015, 990, 181-184.
[124]
Rao, S.I.; Pugh, M.; Nelson, M.; Reddy, J.A.; Klein, P.J.; Leamon, C.P. Development and Validation of a UPLC-MS/MS Method for the Novel Folate-Targeted Small Molecule Drug Conjugate EC1456 and Its Metabolites in Tumor Homogenates from Mice. J. Pharm. Biomed. Anal., 2016, 122, 148-156.
[125]
Wei, L.; Wang, X.; Zhang, P.; Sun, Y.; Jia, L.; Zhao, J.; Dong, S.; Sun, L. An UPLC-MS/MS Method for Simultaneous Quantitation of Two Coumarins and Two Flavonoids in Rat Plasma and Its Application to a Pharmacokinetic Study of Wikstroemia Indica Extract. J. Chromatogr. B., 2016, 1008, 139-145.
[126]
Jacobs, B.A.W.; Rosing, H.; de Vries, N.; Meulendijks, D.; Henricks, L.M.; Schellens, J.H.M.; Beijnen, J.H. Development and validation of a rapid and sensitive UPLC-MS/MS method for determination of uracil and dihydrouracil in human plasma. J. Pharm. Biomed. Anal., 2016, 126, 75-82.
[127]
Dubey, S.K.; Saha, R.N.; Jangala, H.; Pasha, S. Rapid sensitive validated UPLC-MS method for determination of venlafaxine and its metabolite in rat plasma: Application to pharmacokinetic study. J. Pharm. Anal., 2013, 3, 466-471.
[128]
Gu, E.; Huang, C.; Liang, B.; Yuan, L.; Lan, T.; Hu, G.; Zhou, H. An UPLC-MS/MS method for the quantitation of vortioxetine in rat plasma: Application to a pharmacokinetic study. J. Chromatogr. B., 2015, 997, 70-74.
[129]
Reddy, A.V.B.; Venugopal, N.; Madhavi, G.; Reddy, K.G.; Madhavi, V. A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance. J. Pharm. Biomed. Anal., 2013, 84, 84-89.
[130]
Carlier, M.; Stove, V.; De Waele, J.J.; Verstraete, A.G. Ultrafast Quantification of B-Lactam Antibiotics in Human Plasma Using UPLC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2015, 978, 89-94.
[131]
Yu, M.; Hassan, H.E.; Ibrahim, A.; Bauer, K.S.; Kelly, D.L.; Wang, J.B. Simultaneous determination of L-Tetrahydropalmatine and cocaine in human plasma by simple UPLC-FLD method: Application in clinical studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 965, 39-44.
[132]
Shinde, V.P.; Pudage, A.; Jangid, A.; Mistri, H.; Patel, P.K. Application of UPLC-MS/MS for separation and quantification of 3??-Hydroxy tibolone and comparative bioavailability of two tibolone formulations in healthy volunteers. J. Pharm. Anal., 2013, 3, 270-277.
[133]
Jiang, B.; Li, S.; Liu, W.; Yang, Y.; Chen, W.; He, D.; Cheng, X.; Wang, Z.; Chen, W.; Wang, C. Inhibitive activities detection of monoamine oxidases (MAO) A and B inhibitors in human liver MAO incubations by UPLC-ESI-MS/MS. J. Pharm. Biomed. Anal., 2015, 115, 283-291.
Article Metrics
49
3
1
1